OVERVIEW
Three experts will engage in a case-based discussion of clinical data, real-world experience, and optimal management strategies for the treatment of higher-risk myelofibrosis (MF). Patient cases will be introduced and revisited throughout the program to illustrate how experts interpret and apply the latest clinical data to various case scenarios. Discussion will center around the importance of ongoing prognostic risk stratification and symptom assessment; considerations in treatment selection and sequencing, including optimizing dosage, assessing treatment resistance or intolerance, and determining when and how to switch therapies; prevention and mitigation of adverse events; and the role of allogeneic transplant and clinical trials. Learners will be prompted to share their thoughts throughout the program in audience polls, and the faculty will conclude with an interactive Q&A session.
GOAL STATEMENT
The goal of this activity is for learners to be better able to interpret current and emerging data regarding the treatment of myelofibrosis (MF), and to provide learners with a first-hand view of how world experts in MF approach challenging cases.
LEARNING OBJECTIVES
Have increased knowledge regarding the [LIST][ITEM]Molecular targets of available MF therapies[ITEM] Clinical trial data of MF therapies[/LIST] Have greater competence related to [LIST][ITEM]Personalizing treatment of MF with Janus kinase (JAK) inhibitors[/LIST] Demonstrate greater confidence in their ability to [LIST][ITEM]Integrate new data into the management of MF[LIST]
ACCREDITATION STATEMENT
In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. [JALOGO][MEDSCAPE]
[bold]For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of 1.5 [italic][bold]AMA PRA Category 1 Credit(s)™[/bold][/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Marriott Marquis San Diego Marina
Room: Grand Ballroom 5-6
333 W Harbor Drive
San Diego, California , 92101
United States
Friday Satellite Symposium on Case Challenges in Myelofibrosis for the Community Clinician, preceding the 65th Annual Meeting and Exposition
Supported by an independent educational grant from [bold]CTI BioPharma Corp. [/bold]